686 articles · page 35 of 58
Federal Circuit Summary Before O’Malley , Taranto, and Stark; Partial En Banc Decision before Prost, Newman, Lourie, Dyk, Moore, O’Malley, Reyna, Wallach, Taranto, Chen, Hughes, and Stoll. Appeal from the Patent Trial and Appeal Board. Summary:…
Patent Owner’s Given New Rights in Trial Practice Guide Update The Federal Register will issue a notice updating the Patent Trial & Appeal Board (PTAB) Trial Practice Guide on Monday, August 13, 2018. You can find a copy of this notice in the…
Federal Circuit Summary Before Prost, Dyk , and O’Malley. Appeal from the Patent and Trial Appeal Board. Summary: An IPR petitioner lacks standing to appeal an adverse decision by the Board if it sells no infringing products and there is no risk of…
Federal Circuit Summary Before Newman , Lourie, and Reyna. Appeals from the Patent Trial and Appeal Board. Summary: A party did not waive SAS -based relief in an IPR appeal when it requested remand for consideration of non-instituted claims shortly after…
CAFC Emphasizes Flexibility of its Printed Publication Jurisprudence Last week, I pointed out that the Federal Circuit faulted the Patent Trial & Appeal Board (PTAB) for its narrow public accessibility analysis in Medtronic, Inc. v. Barry . Given the de…
Public Accessibility: A Fact Intensive Inquiry Yesterday I highlighted a significant decision for Patent Trial & Appeal Board (PTAB) practitioners pertaining to Real-Party-In-Interest (RPI) and privity determinations, Applications in Internet Time, LLC v.…
Recalibration of RPI/Privy Perspectives Post-WiFi Prior to the Federal Circuit’s decision in WiFi One, real-party-in-interest/privy disputes in AIA trials were the sole province of the Patent Trial & Appeal Board (PTAB). Now that the softened appeal…
On July 20, 2018, the Federal Circuit held that tribal sovereign immunity is not available as a defense in IPR. Allergan Pharmaceuticals owned patents that it had asserted in litigation against various generic pharmaceutical manufacturers, including Mylan…
Federal Circuit Denies Tribal Sovereign Immunity from PTAB Proceedings Last Friday, the Federal Circuit affirmed the Patent Trial & Appeal Board’s (PTAB) denial of tribal sovereign immunity as a patent owner defense to an AIA trial challenge. The…
Federal Circuit Summary Before Dyk, Moore , and Reyna. Appeal from the Patent Trial and Appeal Board. Summary: Tribal sovereign immunity does not shield Indian Tribe owned patents from IPR. Generic drug manufacturers petitioned for IPR of Allergan’s…
Political Theater & Patent Reform The Stronger Patent Act has failed to gain traction for several years now . The Bill is deemed to one-sided, proposing legislative changes that would effectively kill AIA trial proceedings. Strangely, a new bill was…
Written by: Brandon G. Smith and Nicole R. Townes Federal Circuit Summary Before Moore , Wallach, and Taranto. Appeal from the Patent Trial and Appeal Board. Summary : The Supreme Court’s decision in SAS Institute Inc. v. Iancu requires the Board in…
